Cytotoxic effect of immunoconjugate composed of glucose-oxidase coupled to an anti-ganglioside (G(D2)) antibody on spheroids

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 3177-3178

  Heiss, Peter ^a   Bernatz, Sabine ^a   Bruchelt, Gernot ^b   Senekowitsch Schmidtke, Reingard ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Anti ganglioside G(D2) antibody; Glucose oxidase; Immunoconjugate; Neuroblastoma; Spheroids (MCTS)

Indexed keywords

ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; GANGLIOSIDE ANTIBODY; GLUCOSE OXIDASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL;

ANTINEOPLASTIC ACTIVITY; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; TUMOR SPHEROID;

ANTIBODIES, MONOCLONAL; GANGLIOSIDES; GLUCOSE OXIDASE; HUMANS; IMMUNOCONJUGATES; NEUROBLASTOMA; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 0030828430     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Stiller C: Trends in Neuroblastoma in Great Britain: Incidence and Mortality, 1971-1990. Eur J Cancer 29A: 1008-1012, 1993.
2. D2 antibody ch14.18 in patient with neuroblastoma. Eur J Cancer 31A(2): 261-267, 1995.